Genome-wide Association Between LRRK2 Variants and Risk for Acute Respiratory Distress Syndrome
Tiffanie K. Jones(University of Pennsylvania), Nuala J. Meyer(Translational Therapeutics (United States)), V. Eric Kerchberger(Vanderbilt University Medical Center), C.A.G. Ittner(University of Pennsylvania), Todd A. Miano(University of Pennsylvania), Brian J. Anderson(University of Pennsylvania), H.M. Giannini(Lung Institute), S. Obeidalla(Vanderbilt University Medical Center), K.C. Housel(University of Pennsylvania), Rui Feng(University of Pennsylvania), John P. Reilly(University of Pennsylvania), A.P. Turner(Pulmonary and Allergy Associates), M.G.S. Shashaty(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), Lorraine B. Ware(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
|Journal of the American College of Cardiology|2011|685